These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2496553)

  • 1. Low doses of high-potency antithymocyte globulin (ATG) in severe aplastic anemia: experience with the Mexican ATG.
    Delgado-Lamas JL; López-Karpovitch X; Marín-López A; Romero-García F; Ruiz-Argüelles GJ; Ruiz-Gonzalez DS; Taboada C; Vázquez-Villegas V; Elena Zarzosa M
    Acta Haematol; 1989; 81(2):70-4. PubMed ID: 2496553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in children.
    Matloub YH; Smith C; Bostrom B; Koerper MA; O'Leary M; Khuder S; Smithson WA; Nickerson HJ; Silberman T; Hilden J; Moertel CL; Month S; Monteleone P; Ramsay NK
    J Pediatr Hematol Oncol; 1997; 19(2):110-4. PubMed ID: 9149739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Atta EH; Lima CBL; Dias DSP; Clé DV; Bonduel MM; Sciuccati GB; Medeiros LA; Oliveira MM; Salvino MA; Garanito MP; Blum Fonseca PB; Saad STO; Calado RT; Scheinberg P
    Ann Hematol; 2017 Nov; 96(11):1907-1914. PubMed ID: 28815305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
    Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y
    Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum.
    Means RT; Krantz SB; Dessypris EN; Lukens JN; Niblack GD; Greer JP; Flexner JM; Stein RS
    Am J Med; 1988 Apr; 84(4):678-82. PubMed ID: 3261125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithymocyte globulin, cyclosporine, and prednisone for the treatment of severe aplastic anemia in children. A pilot study.
    Matloub YH; Bostrom B; Golembe B; Priest J; Ramsay NK
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):104-6. PubMed ID: 8166362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplant in severe aplastic anemia.
    Atta EH; de Sousa AM; Schirmer MR; Bouzas LF; Nucci M; Abdelhay E
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1876-82. PubMed ID: 22796534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study.
    Chuncharunee S; Wong R; Rojnuckarin P; Chang CS; Chang KM; Lu MY; Hwang WL; Koh LP; Chen TY; Leung AY; Norasetthada L; Wang SC; Chang MC; Wu KH; Issaragrisil S
    Int J Hematol; 2016 Oct; 104(4):454-61. PubMed ID: 27376944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A successful desensitization protocol for horse-derived antithymocyte globulin in severe aplastic anemia.
    Demir E; Cigerci Günaydın N; Karadaş N; Gülen F; Tanac R; Yılmaz D
    Pediatr Allergy Immunol; 2015 Mar; 26(2):168-72. PubMed ID: 25605658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
    Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Biancotto A; Wu CO; Young NS
    N Engl J Med; 2011 Aug; 365(5):430-8. PubMed ID: 21812672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
    Atta EH; Dias DS; Marra VL; de Azevedo AM
    Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia.
    Gluckman E; Esperou-Bourdeau H; Baruchel A; Boogaerts M; Briere J; Donadio D; Leverger G; Leporrier M; Reiffers J; Janvier M
    J Autoimmun; 1992 Apr; 5 Suppl A():271-5. PubMed ID: 1503621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cyclophosphamide compared with antithymocyte globulin for treatment of acquired severe aplastic anemia.
    Zhang F; Zhang L; Jing L; Zhou K; Wang H; Peng G; Li Y; Li Y; Li J; Ye L; Shi L; Fan H; Zhao X; Chu Y; Hao Y; Wang J
    Exp Hematol; 2013 Apr; 41(4):328-34. PubMed ID: 23313080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin.
    Fu R; Chen T; Song J; Wang G; Li L; Ruan E; Liu H; Wang Y; Wang H; Xing L; Wu Y; Liu H; Qu W; Shao Z
    Medicine (Baltimore); 2017 Feb; 96(6):e5905. PubMed ID: 28178130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and complete reconstitution of autologous haemopoiesis after cord blood infusion in treatment-naive patients with severe aplastic anemia receiving high-dose cyclophosphamide/ATG therapy.
    Li Y; Sheng Z; Niu S; Ge L; Ren C; Zou Y
    Eur J Haematol; 2013 Jan; 90(1):45-50. PubMed ID: 23106334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.